Deva Holding AS

IS:DEVA Turkey Drug Manufacturers - Specialty & Generic
Market Cap
$350.83 Million
TL12.44 Billion TRY
Market Cap Rank
#20219 Global
#220 in Turkey
Share Price
TL62.20
Change (1 day)
+2.22%
52-Week Range
TL52.35 - TL80.65
All Time High
TL102.39
About

Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; sysyemic hormanal preparations; anti-infective and antiparasitic products for systemic use; food supplements; and electrolyte solutions. It also provides products in the areas of urogenital system and sex hormones, blood and … Read more

Deva Holding AS (DEVA) - Total Assets

Latest total assets as of September 2025: TL35.50 Billion TRY

Based on the latest financial reports, Deva Holding AS (DEVA) holds total assets worth TL35.50 Billion TRY as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Deva Holding AS - Total Assets Trend (2005–2024)

This chart illustrates how Deva Holding AS’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Deva Holding AS - Asset Composition Analysis

Current Asset Composition (December 2024)

Deva Holding AS's total assets of TL35.50 Billion consist of 41.3% current assets and 58.7% non-current assets.

Asset Category Amount (TRY) % of Total Assets
Cash & Equivalents TL0.00 3.2%
Accounts Receivable TL4.93 Billion 16.6%
Inventory TL4.73 Billion 15.9%
Property, Plant & Equipment TL0.00 0.0%
Intangible Assets TL5.86 Billion 19.7%
Goodwill TL30.86 Million 0.1%

Asset Composition Trend (2005–2024)

This chart illustrates how Deva Holding AS's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Deva Holding AS's current assets represent 41.3% of total assets in 2024, an increase from 0.0% in 2005.
  • Cash Position: Cash and equivalents constituted 3.2% of total assets in 2024, up from 2.2% in 2005.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 4.0% in 2005.
  • Asset Diversification: The largest asset category is intangible assets at 19.7% of total assets.

Deva Holding AS Competitors by Total Assets

Key competitors of Deva Holding AS based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

Deva Holding AS - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.46 - 0.68

Moderate asset utilization - Deva Holding AS generates 0.52x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 0.23% - 23.03%

Moderate ROA - For every $100 in assets, Deva Holding AS generates $ 0.23 in net profit.

Deva Holding AS - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.71 1.57 1.97
Quick Ratio 1.06 0.95 1.34
Cash Ratio 0.00 0.00 0.00
Working Capital TL6.02 Billion TL 4.49 Billion TL 961.62 Million

Deva Holding AS - Advanced Valuation Insights

This section examines the relationship between Deva Holding AS's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.49
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -8.3%
Total Assets TL29.73 Billion
Market Capitalization $62.43 Million USD

Valuation Analysis

Below Book Valuation: The market values Deva Holding AS's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Deva Holding AS's assets decreased by 8.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Deva Holding AS (2005–2024)

The table below shows the annual total assets of Deva Holding AS from 2005 to 2024.

Year Total Assets Change
2024-12-31 TL29.73 Billion -8.26%
2023-12-31 TL32.40 Billion +275.73%
2022-12-31 TL8.62 Billion +69.77%
2021-12-31 TL5.08 Billion +64.51%
2020-12-31 TL3.09 Billion +45.69%
2019-12-31 TL2.12 Billion +27.03%
2018-12-31 TL1.67 Billion +32.79%
2017-12-31 TL1.26 Billion +23.48%
2016-12-31 TL1.02 Billion +2.47%
2015-12-31 TL992.95 Million +11.13%
2014-12-31 TL893.53 Million +8.09%
2013-12-31 TL826.63 Million +14.29%
2012-12-31 TL723.26 Million +8.56%
2011-12-31 TL666.25 Million +6.98%
2010-12-31 TL622.80 Million +17.86%
2009-12-31 TL528.42 Million +7.89%
2008-12-31 TL489.79 Million +27.13%
2007-12-31 TL385.28 Million +32.45%
2006-12-31 TL290.88 Million +6.48%
2005-12-31 TL273.18 Million --